AHNAK2 with ABCC2, RNF43, and GSPT2 were chosen as a 4-gene signature highly related to disease progression in patients with unresectable metastatic GC, and this significantly increased the accuracy in predicting outcomes of GC in validation datasets (GSE-15081 and TCGA) [76]. Here, AHNAK2 is linked to gastric cancer.